RELENT (RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities) will host a symposium in Vienna on March 6, 2020 to share the results of its research. The Horizon 2020 funded project was designed to develop individualised treatment for chronic autoimmune diseases, such as rheumatoid arthritis and vasculitis, that cause considerable mortality and morbidity, both from uncontrolled disease and treatment-associated co-morbidities like infection and malignancy.

Started in 2015, the RELENT Consortium is led by the Medical University of Vienna and has brought together a multidisciplinary group of scientists and clinical investigators from different EU and Non-EU countries. The project co-ordinator, Professor Renate Kain, said “Excellent collaborative work over the past 5 years has resulted in major achievements, highlights of which will be presented at an open International Symposium to be held in Vienna on the 6th March 2020”. The novel findings generated by the RELENT Consortium have important implications for better and more precise treatment of chronic autoimmune disease. They need to be widely known both by fellow investigators and the public at large, because of the their implications for the development of future EU health research and medical technologies.

The International Symposium is open to the general public and its participation is free of charge. The program includes presentations by RELENT Partners and Keynote Lectures by invited keynote speakers. The Symposium should stimulate discussion and ideas between all interested parties, including basic and clinical scientists, industry partners, stakeholders such as patients, students and the media / press. The participants will have the opportunity, following agreement with the organisation team, to display a flyer, poster or roll-up that is in line with the project’s topic.

We would like to invite all interested to register here for his/her participation in the event or to contact the organisation team at relent_arttic@ for any query.